单心卡斯特曼病复杂与支气管炎消灭症:来自中国的一项单中心回顾性研究
Yan-Ting Liu1, Jun-Feng Zhen2, Yu-Han Gao1
1Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
British journal of haematology
|April 10, 2025
概括
支气管炎消灭性 (BO) 是单心卡斯特曼病 (UCD) 的严重并发症. 患有BO的UCD患者经常出现深层淋巴结参与和副质,需要进行肺移植以改善生存率.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 支气管炎消灭性 (BO) 是一种罕见的,危及生命的并发症,也是单心卡斯特曼病 (UCD) 死亡的主要原因.
- 有限的研究存在于UCD患者开发BO的特定特征.
研究的目的:
- 调查由BO复杂的UCD患者的临床特征,结果和治疗影响.
主要方法:
- 在一个中心诊断的281名UCD患者的回顾性分析.
- 鉴定了18名患者 (6.4%) 的同时发生的BO.
- 具有和没有BO的UCD患者之间的临床特征和存活率的比较.
主要成果:
- 患有BO的UCD患者在较年轻时被诊断出来,并且深层淋巴结参与率 (94.4%) 和副瘤性囊 (83.3%) 较高.
- 严重的BO (预测的1秒内强迫呼气量:20.9%) 是普遍存在的,61.1%的人在手术后发展到BO.
- 完全切除UCD并没有阻止BO进展;肺移植在严重的BO病例中显著改善了生存率.
结论:
- 患有UCD-BO的患者表现出明显的临床特征.
- 对UCD的外科切除不足以控制或预防BO进展.
- 肺移植是改善UCD患者严重BO预后的关键干预措施.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features
200
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
200
COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144
Lung Capacity
48.1K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
48.1K
Cystic Fibrosis: Management
114
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
114


